Drug Profile
Research programme: amyotrophic lateral sclerosis therapeutics - Myometrics
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Myometrics
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Amyotrophic lateral sclerosis
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Amyotrophic-lateral-sclerosis in United Kingdom
- 01 Aug 2016 Early research in Amyotrophic lateral sclerosis in United Kingdom (unspecified route)